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Decoy molecules were used to increase the productivity of P450 holoenzyme variants 
Hydroxylation and epoxidation reactions were improved dramatically as was sulfoxidation 
A heme domain peroxygenase variant (Thr268Glu) was used to catalyse P450 activity with 
H2O2 
The peroxygensae catalysed sulfoxidation > epoxidation > benzylic C-H hydroxylation 




Perfluorinated decoy molecules based on a combination of fatty and amino acids were used to 
enhance hydroxylation, epoxidation and sulfoxidation reactions of P450Bm3. The combination of 
amino acid derived second generation decoy molecules, with the rate accelerating variant R19 
(R47L/Y51F/H171L/Q307H/N319Y) displayed the highest oxidation rates. Mutation of Thr268 to 
Glu (Bm3TE) converted the heme domain to a H2O2 utilising peroxygenase. This Bm3TE variant 
displayed significant peroxygenase activity towards all the substrates tested with a preference for 
methylthiobenzene sulfoxidation. However, the addition of decoy molecules did not improve the 
efficiency of this variant. 
 









P450, cytochrome P450; P450Bm3, CYP102A1 from Bacillus megaterium; IPTG, Isopropyl β-D-
1-thiogalactopyranoside; BID, Barrier discharge Ionization Detector; WT, wild-type; R19, 
(R47L/Y51F/H171L/Q307H/N319Y); Bm3TE, Thr268 to Glu variant of the CYP102A1 heme 
domain; NADPH, reduced nicotinamide adenine dinucleotide phosphate; NADH, reduced 
nicotinamide adenine dinucleotide; FAD, flavin adenine dinucleotide; FMN, flavin 
mononucleotide; PFC, perfluorocarboxcylic acid; PFC9-L-Ala, N-perfluorononanoyl-L-alanine; 





Cytochromes P450 (P450s) are a family of enzymes that carry out oxidative transformations 
including hydroxylations, epoxidations, sulfoxidation and other more complex reactions.[1] As a 
result these enzymes offer advantages over traditional methods of synthesis for carbon-hydrogen 
bond hydroxylation in that the reaction occurs with high regio- and stereoselectivity in a single step 
under mild conditions.[2] Most P450s catalyse CH bond hydroxylation via a high-valent iron-oxo 
radical cation intermediate which abstracts a hydrogen from the substrate before undergoing an 
oxygen rebound step, labelled the radical rebound mechanism.[3, 4] The key steps of the catalytic 
cycle are, in order, substrate binding, first electron transfer, dioxygen binding, activation of the 
oxygen by delivery of a second electron and proton delivery to enable OO bond cleavage to 
generate Cpd I (Figure 1). The electrons are sourced from a nicotinamide cofactor (NADH or 
NADPH) and delivered via specific electron transfer partners. [5] These reducing cofactors are 
expensive and many attempts have been made to replace them with simpler alternatives or to do 
away the requirement for electron transfer proteins by using hydrogen peroxide (H2O2) as a source 
of oxygen via a shunt mechanism (Figure 1).[6-12]   
The cytochrome P450Bm3 from Bacillus megaterium rapidly oxidises long chain fatty acid 
substrates (C12 to C16) close to the omega terminus.[13, 14] It, along with other members of the 
CYP102A subfamily, is unusual compared to other bacterial counterparts in that it is fused to a 
domain which contains the organic electron transfer cofactors FAD and FMN. This results in the 
enzyme being self-sufficient in that it requires no other external proteins.[14] P450Bm3 is soluble, 
easy to produce and sources its electrons from NADPH over NADH.[15] It has been adapted for the 
selective hydroxylation of a broad range of substrates through rational protein engineering.[16, 17] 
Directed evolution has also been used to expand the substrate range of P450Bm3 as well as increase 
its thermostability and to improve its activity with H2O2.[6, 14, 18, 19] In addition it has recently 
been modified to enable to it to carry out non-physiological P450 chemistry, for example isoforms 
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which enable the cyclopropanation, amination and aziridination of various substrates have been 
reported.[20]  
These directed evolution studies have highlighted that P450Bm3 can be enhanced by making 
alterations outside of the active site. These mutations alter the conformation of the enzyme to 
enhance its activity but do not alter the active site architecture and so maintain the product regio-
selectivity, of the WT enzyme.[21-24] The conformations adopted by these variants more closely 
resembles those of the fatty acid bound form of the enzyme and lengthens the heme-iron axial water 
bond.[22, 24] One example of such a rate accelerating mutant is the 
R47L/Y51F/H171L/Q307H/N319Y (R19) variant of P450Bm3, which enhanced the oxidation of 
hydrophobic unnatural substrates.[25, 26]  
Chemically inert decoy molecules have also been used to improve the activity of 
P450Bm3.[27] These promote the oxidation of unnatural substrates such as benzenes, xylenes and 
short chain alkanes by the wild-type (WT) enzyme.[26-29] They work as the fluorinated alkyl chain 
of the decoy molecule is used to fill the substrate access channel of the enzyme and this leads to 
conformational changes. However, they are short enough that sufficient space remains in the active 
site of the enzyme over the heme to allow a substrate to bind.[29] One consequence of this is, as 
with the rate accelerating mutants described above, the regioselectivity of oxidation is largely 
unaffected. We have shown that it is possible to use decoy molecules, in conjugation with the rate 
accelerating mutants of P450Bm3 to significantly enhance the rates of product formation for 
cycloalkane and benzene-derived substrates and improve the productivity of regio- and stereo-
selective biocatalysis reactions.[25, 26] 
 More recently, inspired by the H2O2 utilising CYP152 family of enzymes including 
CYP152A1 (P450BSβ) [30], CYP152A2 (P450CLA) [31] and CYP152B1 (P450SPα) [32], a single 
mutation at threonine 268 was introduced to alter the activity of the P450Bm3 heme domain. 
Threonine 268 is part of the highly conserved acid-alcohol pair used to activate dioxygen. Replacing 
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the threonine alcohol side chain with the acidic glutamate residue allowed the heme domain of 
P450Bm3 to hydroxylate fatty acids using hydrogen peroxide as the oxidant [33].  
For the first time we show that the combination of second generation decoy molecules and 
mutated variants of the holoenzyme result in large increases in the efficiency of benzylic 
hydroxylation, epoxidation and sulfoxidation reactions. We also demonstrate that the threonine 268 
to glutamate heme domain variant (Bm3TE) can catalyse these reactions using hydrogen peroxide 
but that no improvement in oxidation is observed when the decoy molecules are added. 
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2. Experimental  
2.1 General 
General reagents and organics were purchased from Sigma-Aldrich, Tokyo Chemical Industry, 
Chem-Supply or Fluorochem. Isopropyl-β-D-thiogalactopyranoside (IPTG) and buffer components 
were obtained from Astal Scientific (Australia).  UV/Vis spectroscopy was performed on an Agilent 
Cary 60 spectrophotometer.  Gas chromatography was carried out on a Shimadzu Tracera GC with 
Barrier discharge Ionization Detector (BID) detector using an Rt-βDEXse column (30m × 0.32mm 
× 0.25 um). Gas Chromatography-Mass Spectrometry was carried out on a Shimadzu GC-2010 with 
GC–MS-QP2010S detector. The GC methods are provided in the Supplemental section.  
2.2 Protein expression and purification 
Plasmids, pT7 containing the gene encoding the P450Bm3 heme domain Thr268Glu mutant 
(Bm3TE) or pET28 with the WT and R19 holoenzyme genes, were transformed into E. coli BL21 
(DE3) competent cells and grown on LB plate in the presence of ampicillin or kanamycin, 
respectively [21, 33]. A single colony was added to 500 mL of LB media containing trace elements 
solution (CaCl2, ZnSO4.7H2O, MnSO4.H2O, Na2-EDTA, FeCl3.6H2O, CuSO4.5H2O, and 
CoCl2.6H2O) in presence of the relevant antibiotic and incubated at 37 °C and 110 rpm. After 14 h 
incubation the temperature was lowered to 18 °C followed by the addition of 0.02 % v/v benzyl 
alcohol and 2 % v/v ethanol after 30 min. IPTG (100 μM) was then added to induce protein 
expression. Cells were harvested after 24 h by centrifugation (5000 g, 10 min, 4 °C) and resuspended 
in 50 mM buffer pH 7.4 (Tris buffer for Bm3TE and phosphate buffer for holoenzymes; both 
contained 1 mM DTT). The cells were lysed by sonication on ice for 30 min (20 s on, 40 s off) and 
cell debris was removed by centrifugation (37000 g, 20 min, 4 °C). The supernatant was loaded onto 
a DEAE Sepharose column (XK50, 200 mm × 40 mm; GE Healthcare) and eluted using a salt linear 
gradient (100 - 400 mM KCl in Tris buffer for Bm3TE and 80 - 400 mM (NH4)2SO4 in phosphate 
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buffer for holoenzymes). The red coloured fractions which contain the P450 enzyme were combined 
and concentrated by ultrafiltration (1900 g, 4 °C) using 10 and 30 kDa membranes for Bm3TE and 
holoenzymes, respectively, (Vivacell 100, Sartorius). Concentrated protein was desalted using a 
Sephadex G-25 medium grain column (250 mm × 40 mm; GE Healthcare). This was concentrated 
by ultrafiltration as described above to approximately 10 ml before being loaded onto a Source-Q 
ion-exchange column (XK26, 80 mm × 30 mm; GE Healthcare). The proteins were purified on an 
AKTA purifier (GE Healthcare) and eluted using a salt gradient (100 - 400 mM KCl in Tris buffer 
for Bm3TE and 0 - 35% 16 × phosphate buffer for Bm3 holoenzymes). Fractions with A418/A280 > 
0.5 (for both holoenzymes and Bm3TE variant) were collected and concentrated, afterwards an 
equivalent volume of 80% glycerol was added to the protein and filter sterilised before storage at -
20 °C. 
2.3 Activity assays 
The peroxygenase turnover assays for the Bm3TE variant were run in 1 ml Tris buffer (pH 7.4, 100 
mM) at room temperature containing 3 μM enzyme. Substrate (5 mM) and decoy molecule (100 
μM if present) were added. The reaction was started by addition of 60 mM H2O2 and quenched after 
5 min by addition of 400 μl ethyl acetate. The NADPH monnoxygenase turnover assays on the 
holoenzymes were carried out as reported previously (see Supplemental section).[25, 34] 
2.4 Product analysis 
After the NADPH consumption or hydrogen peroxide assays were completed, 990 μL of the reaction 
mixture was mixed with 10 μL of an internal standard solution (p-cresol, 20 mM stock solution in 
DMSO). These mixtures were extracted with 400 μL of ethyl acetate and the organic extracts were 
used directly for GC-MS or GC analysis. Products were initially identified by GC-coelution 
experiments and matching the GC-MS spectra to those of the products (styrene oxide, 1-
phenylethanol and methyl phenylsulfoxide; see supplementary material). Products were calibrated 
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against authentic product standards using the assumption that isomeric products would give 





3.1 P450Bm3 catalysed oxidation of ethylbenzene, styrene and methylthiobenzene 
The rates of NADPH oxidation, product formation and the coupling efficiency for different 
P450Bm3 variants, in the presence and absence of different polyfluorinated carboxylic acids (PFCs), 
were obtained for ethylbenzene, styrene and methylthiobenzene oxidation (Table 1). All the 
combinations tested gave rise to a single major oxidation metabolite which could be identified by 
GC-MS coelution experiments with authentic product standards (Scheme 1). In turnovers of styrene, 
there was an additional minor product which coeluted with and had a MS spectra consistent of an 
aldehyde (<11%) arising from a rearrangement reaction (phenylacetaldehyde, Scheme 1). There was 
also a small amount of a sulfone further oxidation product (<15%) in the turnovers of 
methylthiobenzene. In turnovers of ethylbenzene two minor products were observed and were 
assigned as acetophenone and 2-ethylphenol (Scheme 1).[25]     
The activity of WT Bm3 for oxidation of all three substrates, as measured by the product 
formation rate, was low (PFR; 4 nmol (nmol-CYP)1min1; henceforth abbreviated to min1). In 
line with what has been reported previously for ethylbenzene and styrene the addition of first 
generation decoy molecules perfluorononanoic acid (PFC9) and perfluorodecanoic acid (PFC10) 
improved the activity (ranging from 17- to 214-fold) with all the substrates, while the regio- and 
stereo-selectivity was predominantly maintained (Table 1).[25, 34] Based on these previous studies, 
PFC9 and PFC10 were the optimal compounds in the first generation of decoy molecules, therefore 
longer and shorter PFCs were not examined [34]. 
The rate accelerating variant, R19 increased the activity of substrate oxidation over the WT 
enzyme (Table 1) and its combination with a first generation decoy molecules generated even higher 
product formation activities (466 to 1160 min1 an up to 3-fold improvement over the R19 variant 
alone; Table 1, Figure S1). The 725-fold improvement in PFR of the WT enzyme observed with 
styrene oxidation by the R19 variant in combination with PFC10 was greater than those observed 
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for ethylbenzene and methylthiobenzene (271- and 155-fold, respectively).  The regioselectivity of 
R19-catalysed oxidation of all substrates in the presence or absence of the decoy molecules were 
similar to those of the WT enzyme (Scheme 1). There were no significant changes in the 
stereoselectivity of styrene and methylthiobenzene oxidation. However, the R19 variant was less 
selective for the (R)-enantiomer of 1-phenylethanol compared to the WT enzyme with the 
enantiomeric excess (ee) dropping from 48-62 to 16-30% across the turnovers.  
Second generation decoy molecules have been developed to explore the effect of amino acid 
derived compounds for small molecule oxidation by P450Bm3.[29] The oxidation activity of the 
P450Bm3 WT and R19 variants were tested in presence of PFC9-L-Ala, PFC9-L-Leu and PFC9-L-
Phe (N-perfluorononanoyl-L-alanine, N-perfluorononanoyl-L-leucine and N-perfluorononanoyl-L-
phenyalanine, see supplementary section for structures). The oxidation rates in turnovers of 
ethylbenzene and methylthiobenzene were found to be the greatest when the PFC9-L-Phe decoy 
molecule was added to the WT enzyme (Table1, Figure S1). This resulted in a 248-fold 
improvement with ethylbenzene (PFR 962 ± 32 min−1) and a 146-fold enhancement with 
methylthiobenzene (PFR 502 ± 21 min−1). In terms of styrene oxidation, the highest production rate 
with the WT was observed with addition of PFC9-L-Leu or PFC9-L-Ala (both had a PFR of 255 
min-1, 159-fold improvement over the WT by itself). As with the first generation decoys, the addition 
of these second generation molecules to the WT enzyme resulted in small changes in the 
stereoselectivity of the overall reactions (Table 1, Figure S2). For example, that of ethylbenzene 
benzylic hydroxylation was slightly reduced (Table 1). 
The combination of the second generation of decoy molecules with the R19 variant was also 
studied. All three substrates were oxidised with their maximum product formation rates (PFR) with 
R19/PFC9-L-Leu or R19/PFC9-L-Ala. This arose predominantly due to a superior NADPH rate 
with little or no increase in the coupling efficiency over the R19 variant alone or the WT enzyme 
with the decoy molecules. The greatest PFR was found for the PFC9-L-Leu/R19 combination for 
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the oxidation reaction with ethylbenzene (PFR 1860 ± 100 min-1; 490-fold improvement over WT 
alone). For styrene epoxidation PFC9-L-Ala/R19 was the optimal combination (PFR 1580 ± 100 
min-1; 980-fold improvement). The coupling efficiency of methylthiobenzene oxidation was not 
enhanced to the same degree as the other two substrates but its oxidation rate increased 300-fold 
with the PFC9-L-Leu/R19 combination to yield a PFR of 905 ± 11 min-1. As with the other decoy 
molecule turnovers the combination of the second generation of decoy molecules maintained the 
regio- and stereo-selectivity of the turnovers (Table 1). 
 
3.2. Peroxygenase activity of the Thr268Glu variant of the heme domain of P450Bm3 
The single mutation of threonine 268 to glutamic acid converts the heme domain of P450Bm3 
(Bm3TE) into a H2O2 utilizing peroxygenase variant.[33] The activity of Bm3TE variant was tested 
for the oxidation of ethylbenzene, styrene, and methylthiobenzene. The P450Bm3 holoenzyme 
displayed little peroxygenase activity with these substrates (Figure 2). With styrene and 
ethylbenzene the Bm3TE variant generated 640 nmoles of styrene oxide and 199 nmoles of α-EtOH 
after addition of H2O2. Analysis of the methylthiobenzene turnovers was more complex as H2O2 by 
itself can lead to sulfoxidation. However in the presence of the Bm3TE variant a significant increase 
in sulfoxidation was observed. The oxidation of methylthiobenzene produced of 914 nmols of 
methyl phenyl sulfoxide (versus 80 nmols in the no P450 control). In these peroxygenase turnovers 
the addition of the first or the second generation of decoy molecules showed little to no improvement 
on the oxidation of the substrates. For styrene and ethylbenzene the highest productivity was 
observed in the absence of decoy molecules and significant decreases in the amount of product were 
found when the second generation decoy molecules were used. Small increases in product formation 
were observed in certain instances with methylthiobenzene (Table S1). 
While the regioselectivity of the peroxygenase turnovers were similar to those of the 
holoenzyme monoxygenase activities differences in metabolite formation were observed (Scheme 
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1). In the turnovers of ethylbenzene with Bm3TE variant 15% of the further oxidation product 
acetophenone was detected which was higher than the monooxygenase reactions (0-4%; Scheme 1). 
Changes were observed in the stereoselectivity of the peroxygenase reactions. Oxidation of styrene 
with Bm3TE was less in favor of the R-enantiomer (10-20% ee) compared to the holoenzymes (15-
32%). The stereo-selectivity on oxidation of methylthiobenzene with T268E variant towards R 
enantiomer increased up to 20% (Table S1). The most dramatic change was observed for the 
hydroxylation of ethylbenzene where the peroxygenase reactions favoured the (S)-enantiomer in 




The rates of product formation for ethylbenzene, styrene and methylthiobenzene oxidation with 
P450Bm3 holoenzymes were significantly increased by using decoy molecules. The highest 
activities were observed with the second generation of decoy molecules with the R19 variant. The 
regioselectivity and the stereoselectivity was maintained across both variants in the presence of the 
decoy molecules.  
The Bm3TE heme domain variant was capable of oxidising all of the substrates using H2O2 
instead of molecular dioxygen and NADPH. This variant was more active for the sulfoxidation of 
methylthiobenzene over the epoxidation of styrene and benzylic hydroxylation of ethylbenzene. 
This contrasted with the holoenzyme turnovers which were most effective for ethylbenzene 
oxidation suggesting a potential change in the rate determining step for these reactions. The coupling 
efficiency of methylthiobenzene sulfoxidation, the most reactive functional group to be tested, was 
lowest for the monooxygenase turnovers using the holoenzyme. The addition of decoy molecules 
induced no improvement in the oxidation efficiency of Bm3TE. This infers that there may be a 
change in the rate determining step and the pathway taken during the hydrogen peroxide driven 
turnovers is different from that of the monoxygenase catalytic cycle of the holoenzyme. It is 
hypothesised that the decoy molecules enhance the activity by binding to the enzyme together with 
the substrate overcoming the substrate gate, inducing a conformation change which triggers the first 
electron transfer, subsequent oxygen binding and faster turnover of the catalytic cycle. The second 
generation of decoy molecules have been shown to bind tightly to P450Bm3 and to alter the 
conformation of the enzyme. The crystal structure of PFC9-L-Trp-bound P45Bm3 highlights 
modification in the position of F and G helices, the G/F loop and the I helix.[29]  
The switch in in the stereoselectivity of ethylbenzene hydroxylation towards the (S)-
enantiomer for the peroxygenase mutant compared to the monooxygenase turnovers of the 
holoenzyme is intriguing. This change could be due to a change the binding orientation of the 
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substrate in the mutant, though the regioselectivity of the reaction was not altered. In addition 
minimal changes were observed for the epoxidation of styrene and sulfoxidation of 
methylthiobenzene inferring their positions relative to the heme iron may not be altered. The double 
bond in styrene may provide a more rigid structure leading to less opportunity for movement.  
Another potential explanation for the modified metabolite distribution between the 
peroxygenase and the holoenzyme could be that there may be a change in the relative proportion of 
putative reactive oxygen-bound heme species in the peroxygenase turnovers of the Bm3TE variant. 
Sulfoxidation has been proposed to be able to occur via a hydrogen peroxide bound heme 
intermediate and if this is the case could be a reason as to why methylthiobenzene is the optimal 
substrate for the peroxygenase variant.[35] In contrast benzylic hydroxylations are hypothesised to 
proceed via radical rebound reaction with Cpd I are not as favoured. However further work would 
be required to fully understand these differences. 
 
Conclusion  
The results highlight the important role that decoy molecules can play in accelerating the productive 
oxidation of non-physiological substrates by P450Bm3. They also back up the hypothesis that these 
decoy molecules work by inducing conformational changes which boost the monooxygenase 
catalytic cycle by enhancing the rate of electron transfer. The peroxygenase variant could also 
efficiently oxidise the substrates. Further optimisation of this system could result in simpler and 
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Table 1. Enzyme turnover and coupling efficiency data for WT and the R19 variant of P450Bm3 
with ethylbenzene, styrene and methylthiobenzene. Activities are expressed as the NADPH 
oxidation rate (N) and were measured using a concentration of 0.2 μM CYP enzyme, 50 mM Tris, 
pH 7.4). The coupling efficiency (C) is the percentage efficiency of NADPH utilization for the 
formation of organic products. N and the product formation rates (PFR) are reported as mean  S.D. 
(n  3) and given in nmol(nmol-CYP)–1min–1. [a] These results are in line with what was reported 
previously for these substrate/enzyme/decoy combinations.[25] 
 ethylbenzene  
 N C PFR ee (R) 
WT[a] 71 ± 4 5.3 ± 1.5 3.8 ± 1.2 48 
WT/PFC9[a] 1106 ± 19 74 ± 2 814 ± 33 56 
WT/PFC10[a] 1311 ± 13 49 ± 2 645 ± 33 62 
WT/PFC9-Phe 1560 ± 8 61 ± 2 962 ± 32 39 
WT/PFC9-Leu 1040 ± 24 58± 2 563 ± 13 28 
WT/PFC9-Ala 947 ± 17 51 ± 1 482 ± 4 38 
R19[a] 702 52 366 16 
R19/PFC10[a] 1460 71 1030 30 
R19/PFC9-Phe 2240 ± 85 61 ± 3 1420 ± 26 12 
R19/PFC9-Leu 2830 ± 69 66 ± 6 1860 ± 100 12 
R19/PFC9-Ala 2760 ± 96 63 ± 5 1720 ± 180 20 
 styrene  
 N C PFR ee (R) 
WT[a] 41 ± 1 4.0 ± 0.6 1.6 ± 0.2 18 
WT/PFC9[a] 457 ± 11 32 ± 1 146 ± 4 32 
WT/PFC10[a] 691 ± 7 17 ± 1 117 ± 7 32 
WT/PFC9-Phe 932 ± 25 21 ± 3 194 ± 28 15 
WT/PFC9-Leu 665 ± 10 38 ± 5 255 ± 31 18 
WT/PFC9-Ala 601 ± 14 43± 4 255 ± 14 18 
R19[a] 976 63 611 22 
R19/PFC10[a] 1530 76 1160 28 
R19/P9-Phe 1620 ± 20 63 ± 4 1030 ± 70 18 
R19/P9-Leu 2210 ± 130 67 ± 3 1480 ± 20 18 
R19/P9-Ala 2020 ± 65 78 ± 1 1580 ± 42 26 
 methylthiobenzene  
 N C PFR ee (R) 
WT[ 39 ± 1.4 12 ± 2 3 ± 1 2 
WT/PFC10 267 ± 18 22 ± 3 58 ± 6.6 0 
WT/PFC9-Phe 1770 ± 18 28 ± 1 502 ± 21 1 
WT/PFC9-Leu 1410 ± 23 30 ± 2 423 ± 24 0 
WT/PFC9-Ala 934 ± 31 23 ± 1 213 ± 13 10 
R19 1060 ± 75 31 ± 2 317 ± 15 0 
R19/PFC10 1440 ± 40 32 ± 2 466 ± 27  0 
R19/P9-Phe 2080 ± 14 32 ± 1 660 ± 29 0 
R19/P9-Leu 2880 ± 62 32 ± 0.5 905 ± 11 0 






Scheme 1. Product distributions for the catalysed oxidation of ethylbenzene, styrene and 
methylthiobenzene in the presence and absence of decoy molecules. The products from 
ethylbenzene: 1-phenylethanol and 2-ethylphenol, from styrene: styrene oxide and 
phenylacetaldehyde and from methylthiobenzene: methylphenyl sulfoxide and methylphenyl 
sulfone. Values in in black represent the percentage of products with WT and R19 variant. The 









































Figure 2. GC-MS analysis the hydrogen 
peroxide driven turnovers of a) 
ethylbenzene, b) styrene and c) 
methylthiobenzene with WT Bm3 
holoenzyme (black) and the Bm3TE 
(T268E) variant (grey). The WT 
holoenzyme displayed little to no activity 






Figure 3. Chiral GC analysis of ethylbenzene oxidation illustrating a change in stereo-
selectivity of the Bm3TE variant versus the holoenzymes for 1-phenylethanol. While WT and 
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